Data / Form D filings / EFFRX PHARMACEUTICALS SA
EFFRX PHARMACEUTICALS SA: Form D filings
EFFRX PHARMACEUTICALS SA, a pharmaceuticals company in Freienbach, Switzerland, filed 2 Form D notices with the SEC between 2010 and 2012. The latest, on July 5, 2012, reports an offering of no set size with nothing sold yet.
Find out what EFFRX PHARMACEUTICALS SA does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Wolleraustrasse 41B, Freienbach, Switzerland, CH-88
- Phone
- 41 44 503 7860
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Switzerland
- Year incorporated
- 2009
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1494588
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 5, 2012 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
| Jul 2, 2010 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CHRISTER ROSEN | Executive Officer, Director | |
| FRITZ SCHNEITER | Director | |
| CG JOHANSSON | Director | |
| OSCAR AHLGREN | Director | |
| YVONNE GUNSCH-WEGMANN | Executive Officer | |
| JACOB UITTENBOGAARD | Director | |
| ANDERS WIKLUND | Director | |
| JESPER PARNEVIK | Director | |
| MARSHALL HAYWARD | Executive Officer |
Every Form D from the week of Jul 2, 2012 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EFFRX PHARMACEUTICALS SA reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.